Designing peptide vaccines to broaden recognition and enhance potency - PubMed (original) (raw)
Designing peptide vaccines to broaden recognition and enhance potency
J A Berzofsky. Ann N Y Acad Sci. 1995.
No abstract available
Similar articles
- Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
Shirai M, Pendleton CD, Ahlers J, Takeshita T, Newman M, Berzofsky JA. Shirai M, et al. J Immunol. 1994 Jan 15;152(2):549-56. J Immunol. 1994. PMID: 8283036 - Use of intrinsic and extrinsic helper epitopes for in vivo induction of anti-hepatitis C virus cytotoxic T lymphocytes (CTL) with CTL epitope peptide vaccines.
Shirai M, Chen M, Arichi T, Masaki T, Nishioka M, Newman M, Nakazawa T, Feinstone SM, Berzofsky JA. Shirai M, et al. J Infect Dis. 1996 Jan;173(1):24-31. doi: 10.1093/infdis/173.1.24. J Infect Dis. 1996. PMID: 8537666 - Immunization of mice with lipopeptides bypasses the prerequisite for adjuvant. Immune response of BALB/c mice to human immunodeficiency virus envelope glycoprotein.
Martinon F, Gras-Masse H, Boutillon C, Chirat F, Deprez B, Guillet JG, Gomard E, Tartar A, Levy JP. Martinon F, et al. J Immunol. 1992 Nov 15;149(10):3416-22. J Immunol. 1992. PMID: 1385524 - Current progress in HIV vaccines.
Westblom TU, Belshe RB, Gorse GJ. Westblom TU, et al. Mo Med. 1991 Nov;88(11):762-5. Mo Med. 1991. PMID: 1805131 Review. No abstract available. - Clonal analysis of T-cell responses to the HIV-1 envelope proteins in AIDS vaccine recipients.
Siliciano RF, Bollinger RC, Callahan KM, Hammond SA, Liu AY, Miskovsky EP, Rowell JF, Stanhope PE. Siliciano RF, et al. AIDS Res Hum Retroviruses. 1992 Aug;8(8):1349-52. doi: 10.1089/aid.1992.8.1349. AIDS Res Hum Retroviruses. 1992. PMID: 1361352 Review.
Cited by
- Evolutionary Analysis and Prediction of Peptide Vaccine Candidates for Foot-and-Mouth-Disease Virus Types A and O in Bangladesh.
Momtaz S, Rahman A, Sultana M, Hossain MA. Momtaz S, et al. Evol Bioinform Online. 2014 Nov 3;10:187-96. doi: 10.4137/EBO.S17027. eCollection 2014. Evol Bioinform Online. 2014. PMID: 25452681 Free PMC article. - Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence.
Ahlers JD, Takeshita T, Pendleton CD, Berzofsky JA. Ahlers JD, et al. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10856-61. doi: 10.1073/pnas.94.20.10856. Proc Natl Acad Sci U S A. 1997. PMID: 9380724 Free PMC article. - Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses.
Lim SY, Meyer M, Kjonaas RA, Ghosh SK. Lim SY, et al. J Immune Based Ther Vaccines. 2006 Oct 30;4:6. doi: 10.1186/1476-8518-4-6. J Immune Based Ther Vaccines. 2006. PMID: 17074094 Free PMC article. - Cancer vaccines: translation from mice to human clinical trials.
Maeng H, Terabe M, Berzofsky JA. Maeng H, et al. Curr Opin Immunol. 2018 Apr;51:111-122. doi: 10.1016/j.coi.2018.03.001. Epub 2018 Mar 16. Curr Opin Immunol. 2018. PMID: 29554495 Free PMC article. Review. - Strategies for developing and optimizing cancer vaccines.
Maeng HM, Berzofsky JA. Maeng HM, et al. F1000Res. 2019 May 13;8:F1000 Faculty Rev-654. doi: 10.12688/f1000research.18693.1. eCollection 2019. F1000Res. 2019. PMID: 31131086 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources